Nemus Bioscience Adds to Senior Leadership Team
May 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
LONG BEACH, CA, May 07, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
Nemus Secures Emerald Health as Strategic Majority Investor to help Advance Clinical Development of Novel Cannabinoid-based Therapeutics
January 19, 2018 08:30 ET
|
Nemus Bioscience, Inc.
Nemus Bioscience Receives $400,000 Funding under Convertible Bridge Loan and Closes Initial $1,500,000 Private Placement COSTA MESA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc....
Nemus Bioscience Announces Closing of Convertible Bridge Loan and Anticipated Equity Financing
December 29, 2017 08:30 ET
|
Nemus Bioscience, Inc.
COSTA MESA, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS, “Nemus”) today announced that it entered into agreements with Emerald Health Sciences Inc. (“Emerald”),...
NEMUS Bioscience, Inc. Retains MZ Group as Investor Relations Advisor
March 24, 2015 07:08 ET
|
Nemus Bioscience
COSTA MESA, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- NEMUS Bioscience Inc. (OTCQB: NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities...
NEMUS Bioscience, Inc. initiates anti-infective program with focus on MRSA
March 18, 2015 07:06 ET
|
Nemus Bioscience
COSTA MESA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS) announced today that the company would begin studies concerning the medical utility of cannabinoids as...